Krebs Biochemicals & Industries Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 5.83 | 7.14 | 8.81 |
| Operating Expense | 7.72 | 6.16 | 7.68 |
| Net Profit | -5.40 | -2.48 | -2.34 |
| Net Profit Margin | -92.62% | -34.73% | -26.56% |
| Earning Per Share | -2.50 | -1.15 | -1.09 |
| EBIDTA | -1.89 | 0.99 | 1.14 |
| Effective Tax Rate | -0% | 0% | 0% |
Particulars
Sep 2026
Revenue5.83
Operating Expense7.72
Net Profit-5.40
Net Profit Margin-92.62
Earning Per Share-2.50
EBIDTA-1.89
Effective Tax Rate-0
